Biomarker ID | 424 |
PMID | 19229851 |
Year | 2009 |
Biomarker | Urokinase-type plasminogen activator receptor (uPAR) |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Plasma |
Subjects | Humans |
Regulation | Increased Expression with Biochemical Recurrence |
Odds Ratio/Hazard Ratio/Relative Risk | Univariate: HR: 1.56 |
Effect on Pathways | Pathways Include:-Beta-3 integrin cell surface interactions,Dissolution of fibrin clot,Post-translational modification: biosynthesis of GPI-anchored proteins, Urokinase-type plasminogen activator (uPA) and uPAR-mediated signalingIntegrin beta-5 pathway |
Experiment | Recurrence Vs No recurrence for 5 years |
Type of Biomarker | Prognostic |
Cohort | A cohort of 423 men was used to develop and internally validate the post-operative nomogram for prediction of Biochemical Recurrance. |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | Concordance Index = 86.3% |
Level Of Significance | p<0.001 |
Method Used | enzyme immunoassays |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | PLAUR |